ENTITY
Neuren Pharmaceuticals

Neuren Pharmaceuticals (NEU AU)

38
Analysis
Health CareAustralia
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company. The Company researches neurological and metabolic disorders.
more
Refresh
17 Aug 2023 06:04

S&P/​​​​​​​​​ASX Index Rebalance Preview: Potential Adds Have Outperformed

We forecast 26 changes across the ASX50, ASX100, ASX 200 and ASX300 indices at the September rebalance. There is big flow and impact on a lot of...

Logo
534 Views
Share
bullishWistron Corp
23 Jul 2023 08:41

Index Rebalance & ETF Flow Recap: ASX, SK Telecom, Yuanta ETFs

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
473 Views
Share
bullishData#3 Ltd
19 Jul 2023 05:09

S&P/ASX200 Ad Hoc Index Rebalance & Update to Potential Changes in September

Ventia replaces Blackmores in the ASX200 at the close on 21 July. That also leads to changes to potential adds/deletes in September. WBT and DTL...

Logo
553 Views
Share
bullishVentia
18 Jul 2023 23:04

Ventia Services (VNT) Selected to Join ASX 200 - Not A Surprise

Ventia (VNT AU) was chosen to join the S&P ASX 200 on Friday's close, replacing Blackmores. It was not that much of a surprise. There have been...

Logo
502 Views
Share
16 Jul 2023 11:56

Quiddity Leaderboard ASX Sep 23: Intra-Review Replacement for BKL and Many Other Expected Changes

Blackmores Ltd could be deleted from the ASX 200 index and Neuren Pharmaceuticals or Ventia could become the replacement. This could be announced...

Share
x